James Schmidt, MD
Interventional Cardiology · Wilmington, OHNPI 1467415406
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.2%), travel and lodging and education — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 62.2% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $1,579, more than ten times the $94 reported in 2019. That places this record below the midpoint for interventional cardiology clinicians in OH, where the typical reported total is $4,547.
Across 30 payments — averaging $73.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Medtronic$230
- Abbott$194
- Johnson & Johnson$91
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$88
- Astellas Pharma US Inc$29
- plus $196 from 10 others
What the payments were for
- Travel & lodging$97545%
- Food & beverage$1,16553%
- Education$502%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 5 | $1,363 |
| Medtronic(2 entities) | 3 | $230 |
| Abbott | 2 | $194 |
| Johnson & Johnson | 4 | $91 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $88 |
| Astellas Pharma US Inc | 2 | $29 |
| Cardiovascular Systems Inc. | 2 | $26 |
| Acist Medical Systems, Inc. | 2 | $26 |
| Janssen Scientific Affairs, LLC | 1 | $26 |
| Biotronik Inc. | 1 | $23 |
| Teleflex LLC | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Merck | 1 | $15 |
| Inari Medical, Inc. | 1 | $15 |
| AstraZeneca | 1 | $14 |
| GSK | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Watchman$1,269
- CARDIOMEMS$161
- RESOLUTE ONYX$111
How this compares
$2,190 in reported general payments places this provider in the 30th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Wilmington
- M Niranjan ReddyWilmington$98K
- Gary AnselColumbus$3.3M
- John CheathamColumbus$1.4M
- Carlos Sanchez SotoColumbus$1.1M
- Steven YakubovColumbus$907K
- Timothy HenryCincinnati$605K
- Mitchell SilverColumbus$562K
- John PhillipsColumbus$410K
- John CorlCincinnati$390K
- Santiago GarciaCincinnati$360K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.